Inspection Record

Lynden International Logistics ULC — Health Canada Inspection Findings

Health CanadaInspected 2022-03-07 4 findingsStability and storageDeviation, CAPA, and investigationRegulatory reporting and change controlLaboratory and QC controls

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

2Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

3Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

4Laboratory and QC controls

The quality control department's documentation, labelling, and/or quarantining of raw materials, packaging materials, in-process drugs, and/or bulk drugs was inadequate. Packaging operations were not performed in keeping with the written operating procedures or specifications.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-03-07. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Lynden International Logistics ULC findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search